Healthcare & Medical
Category / Healthcare & Medical
HONG KONG: HONG KONG, Aug 14, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Appl ...
Singapore: SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the “Company” and, together with its subsidiaries, the “Group”) announced its unaudited financial results for ...
HONG KONG: HONG KONG, Aug 8, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R). ...
HONG KONG: HONG KONG, Aug 6, 2025 - (ACN Newswire) - A major breakthrough in surgical embodied intelligence in Robot-Assisted Surgery (RAS) has been achieved in Hong Kong, China. At a press conference held on 5 ...
HONG KONG: HONG KONG, Aug 5, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by C ...
HONG KONG: HONG KONG, Aug 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equi ...
Shanghai: SHANGHAI, July 25, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturi ...
TOKYO: Olympus co-founds Swan EndoSurgical with Revival Healthcare Capital ...
SINGAPORE,: SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Bo ...
HONG KONG: HONG KONG, July 9, 2025 - (ACN Newswire) - Cornerstone Robotics (CSR) has announced the first formal clinical investigation of its Hong Kong-developed surgical robotic system at Portsmouth Hospitals U ...
HONG KONG: HONG KONG, July 4, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shang ...
NEW YORK: Technology Co-Developed by the U.S. Department of Veteran Affairs and Emory University ...
HONG KONG: - Kidney Disease Treatment into a New Era of Precision Management
...
HONG KONG: HONG KONG, Jun 9, 2025 - (ACN Newswire) - At the 62nd European Renal Association Congress (ERA 2025), Everest Medicines unveiled new clinical data on EVER001 (previously known as XNW1011), a next-gene ...
